Darvys Pharma

or click here to view
the YouTube version.

	NOVELL Pharma (www.novellpharm.com) A major pharmaceutical and manufacturing concern that was born in 1998 following its purchase of the Burroughs-Wellcome (now GSK) facility in Jakarta, Indonesia. The high international standards of quality of its manufacturing plant are continuously monitored and supervised by a team of Australian experts helping Novell maintain a seal of approval from the Australian Therapeutic Goods Administration (TGA) – recognized as one of the most stringent and exacting regulatory agencies in the world. In less than 5 years, Novell began exporting its products to Europe, South America, Africa, the Middle East and selected countries in Southeast Asia. Novell is supplying ubiquinone for the DARVYS product ESSENVIDA®, in addition to a full range of products including KEON, NEUROTON and VISTRA (over 20 already submitted) for the company’s selected therapeutic fields now either approved or awaiting approval from the Philippine FDA.

	BIOCODEX SA (www.biocodex.com) BIOCODEX S.A. is an international research and development pharmaceutical company based in France. It has a world leading product in the field of gastroenterology, while also having a sizeable share of the market with products in the field of CNS, ENT and General Medicine. Darvys Pharma has the distinction of introducing these remarkable products of Biocodex into the Philippine market in the near future.

	PHASILAB (www.phasilab.com) A research and development company based in France that specializes in consumer ENT and cosmeceutical products. Phasilab’s product PHASIMAR, a purified seawater spray, the first of its kind to be technologically adjusted to the physiological pH of the human body will be available in 2 variants – as a nose rinse, indicated for rhinitis, sinusitis and regular nasal hygiene and as an ear (auricular) cleanser for regular ear hygiene. It is safe for use by all members of the family, including infants and pregnant women.

	BANGKOK DRUG CO., LTD. (www.bangkokdrug.com) (Pharma Alliance) Bangkokdrug was founded in 1990 is the developer and manufacturer of the leading capsaicin based topical product, CAPSIKA, which is highly effective for the relief of muscular aches and pains. The efficacy and safety of the product has been demonstrated in various published clinical trials. The product is available in medium and high strength and is available in various formats. Darvys Pharma will be introducing the product to the Philippine market soon.

	RIEMSER PHARMA (www.riemser.de) A major manufacturing concern based in Germany. Riemser’s products are focused on the cardiovascular specialties. As a start, they will be supplying DARVYS with LANITOP® (methyl-digoxin), an improvement over the basic drug digoxin, widely prescribed locally and which is indicated for cardiac insufficiency. LANITOP® provides the advantages and benefits of a faster onset of action, higher peak serum concentrations and a lower dosing scheme. LANITOP® is expected to be approved in 2010.

	AOP Orphan (www.aoporphan.com) AN Austrian-based R&D company focused on highly specialized products (e.g. orphan drugs), mostly for niche or rare conditions. AOP Orphan will be supplying DARVYS with the first-ever product indicated for what has been identified as the Philippine’s most widespread form of addiction – alcoholism. The product ETHYLEX® (naltrexone) is already under registration with the Philippine FDA. It is also indicated for other forms of addiction.

	RBC-MDC CORPORATION (www.rbc-mdc.com) Darvys' exclusive distributor, RBC-MDC Corporation was organized in 01 July 2000, with the objective of providing a more viable solution to service the needs of dispensing doctors for various pharmaceutical products. It does direct distribution to doctors within Metro Manila and nearby Luzon key areas, while that of Visayas, Mindanao, Bicol Region, Ilocos & Cagayan Valley are done via a door-to-door tie-up with DHL, WWWExpress.

NEW, INCOMING PARTNERS – At this very moment, DARVYS is about to sign contracts with suppliers of exciting new products including:

From the U.K. - The leading consumer product for managing snoring (a condition that affects up to 25% of the population!). It will be available in convenient and affordable oral/nasal strips and sprays

From Thailand – a powerful capsaicin-based topical treatment for rheumatoid and osteoarthritis, muscular aches and sprains that is backed up by published medical evidence

From France – the first saliva substitute, for patients suffering from dry mouth due to physiological disorders or as a side effect of certain treatments (e.g. botulinum toxin injections, chemotherapy, etc.)